CureVac (CVAC) shares were up 32% in recent Thursday premarket activity after the company and BioNTech (BNTX) said they signed an agreement under which BioNTech will acquire CureVac in an all-stock deal.
Liminatus Pharma (LIMN) stock was 26% higher, shaving Wednesday's loss.
Klotho Neurosciences (KLTO) shares were 19% higher, erasing the previous session's fall.
Oracle (ORCL) stock was 9% higher, a day after the company reported higher fiscal Q4 non-GAAP earnings and revenue.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。